327 related articles for article (PubMed ID: 27591864)
21. [Use of Trabecular Bone Score as a complementary approach to DXA for fracture risk assessment in clinical practice].
Hans D; Shevroja E; Lamy O
Rev Med Suisse; 2017 Apr; 13(559):844-850. PubMed ID: 28727341
[TBL] [Abstract][Full Text] [Related]
22. Fracture Risk Prediction by Non-BMD DXA Measures: the 2015 ISCD Official Positions Part 2: Trabecular Bone Score.
Silva BC; Broy SB; Boutroy S; Schousboe JT; Shepherd JA; Leslie WD
J Clin Densitom; 2015; 18(3):309-30. PubMed ID: 26277849
[TBL] [Abstract][Full Text] [Related]
23. Trabecular Bone Score: A New DXA-Derived Measurement for Fracture Risk Assessment.
Silva BC; Leslie WD
Endocrinol Metab Clin North Am; 2017 Mar; 46(1):153-180. PubMed ID: 28131130
[TBL] [Abstract][Full Text] [Related]
24. Effect of vertebral exclusion on TBS and FRAX calculations.
White R; Binkley N; Krueger D
Arch Osteoporos; 2018 Aug; 13(1):87. PubMed ID: 30128621
[TBL] [Abstract][Full Text] [Related]
25. FRAX tool in type 2 diabetic subjects: the use of HbA
Valentini A; Cianfarani MA; De Meo L; Morabito P; Romanello D; Tarantino U; Federici M; Bertoli A
Acta Diabetol; 2018 Oct; 55(10):1043-1050. PubMed ID: 29980834
[TBL] [Abstract][Full Text] [Related]
26. The utility and limitations of using trabecular bone score with FRAX.
Martineau P; Leslie WD
Curr Opin Rheumatol; 2018 Jul; 30(4):412-419. PubMed ID: 29528866
[TBL] [Abstract][Full Text] [Related]
27. Utility of trabecular bone score in the evaluation of osteoporosis.
Martineau P; Silva BC; Leslie WD
Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):402-410. PubMed ID: 28857846
[TBL] [Abstract][Full Text] [Related]
28. FRAX without BMD can be used to risk-stratify Veterans who recently sustained a low trauma non-vertebral/non-hip fracture.
Sagalla N; Colón-Emeric C; Sloane R; Lyles K; Vognsen J; Lee R
Osteoporos Int; 2021 Mar; 32(3):467-472. PubMed ID: 32885318
[TBL] [Abstract][Full Text] [Related]
29. Use of dual energy X-ray absorptiometry, the trabecular bone score and quantitative computed tomography in the evaluation of chronic kidney disease-mineral and bone disorders.
Pocock N
Nephrology (Carlton); 2017 Mar; 22 Suppl 2():19-21. PubMed ID: 28429557
[TBL] [Abstract][Full Text] [Related]
30. BONE MINERAL DENSITY AND PROBABILITY OF OSTEOPOROTIC FRACTURES IN WOMEN WITH TYPE II DIABETES MELLITUS.
Grygorieva N; Musiienko A; Zaverukha N; Bystrytska M; Povoroznyuk R
Wiad Lek; 2022; 75(12):2920-2925. PubMed ID: 36723304
[TBL] [Abstract][Full Text] [Related]
31. Trabecular Bone Score Reflects Trabecular Microarchitecture Deterioration and Fragility Fracture in Female Adult Patients Receiving Glucocorticoid Therapy: A Pre-Post Controlled Study.
Chuang MH; Chuang TL; Koo M; Wang YF
Biomed Res Int; 2017; 2017():4210217. PubMed ID: 28127556
[TBL] [Abstract][Full Text] [Related]
32. ADDING VFA TO DXA IDENTIFIES FRACTURE RISK IN A WAY NOT DUPLICATED BY OTHER MEASURES.
Ginther JP; Ginther AW; Brodersen LD
Endocr Pract; 2017 Dec; 23(12):1375-1378. PubMed ID: 29019717
[TBL] [Abstract][Full Text] [Related]
33. [10-year risk of fractures (FRAX) in people with diabetes type 2].
Mazurenko ES; Malutina SK; Shcherbakova LV; Hrapova YV; Isaeva MP; Rymar OD
Ter Arkh; 2019 Oct; 91(10):76-81. PubMed ID: 32598635
[TBL] [Abstract][Full Text] [Related]
34. Prediction of osteoporotic fragility re-fracture with lumbar spine DXA-based derived bone strain index: a multicenter validation study.
Messina C; Rinaudo L; Cesana BM; Maresca D; Piodi LP; Sconfienza LM; Sardanelli F; Ulivieri FM
Osteoporos Int; 2021 Jan; 32(1):85-91. PubMed ID: 32936366
[TBL] [Abstract][Full Text] [Related]
35. Do patients that fracture with normal DXA-measured BMD have normal bone?
Bandaru S; Hare K; Krueger D; Binkley N
Arch Osteoporos; 2020 May; 15(1):70. PubMed ID: 32394003
[TBL] [Abstract][Full Text] [Related]
36. Trabecular bone score may improve FRAX® prediction accuracy for major osteoporotic fractures in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Cohort Study.
Iki M; Fujita Y; Tamaki J; Kouda K; Yura A; Sato Y; Moon JS; Winzenrieth R; Okamoto N; Kurumatani N
Osteoporos Int; 2015 Jun; 26(6):1841-8. PubMed ID: 25752623
[TBL] [Abstract][Full Text] [Related]
37. Rationale of the Spanish FRAX model in decision-making for predicting osteoporotic fractures: an update of FRIDEX cohort of Spanish women.
Azagra R; Zwart M; Encabo G; Aguyé A; Martin-Sánchez JC; Puchol-Ruiz N; Gabriel-Escoda P; Ortiz-Alinque S; Gené E; Iglesias M; Moriña D; Diaz-Herrera MA; Utzet M; Manresa JM;
BMC Musculoskelet Disord; 2016 Jun; 17():262. PubMed ID: 27317560
[TBL] [Abstract][Full Text] [Related]
38. Association of C-peptide level with bone mineral density in type 2 diabetes mellitus.
Yang H; Bai J; Li L; Yang Y; Zhang Y; Lv H; Fu S
Osteoporos Int; 2023 Aug; 34(8):1465-1476. PubMed ID: 37204453
[TBL] [Abstract][Full Text] [Related]
39. Trabecular bone score (TBS): Method and applications.
Martineau P; Leslie WD
Bone; 2017 Nov; 104():66-72. PubMed ID: 28159710
[TBL] [Abstract][Full Text] [Related]
40. The role of advanced glycation end products in fracture risk assessment in postmenopausal type 2 diabetic patients.
Gao L; Liu C; Hu P; Wang N; Bao X; Wang B; Wang K; Li Y; Xue P
Front Endocrinol (Lausanne); 2022; 13():1013397. PubMed ID: 36578954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]